Sinohealth Technology Holdings Limited (HKG:2361)
Hong Kong · Delayed Price · Currency is HKD 3.940
0.00 (0.00%)
At close: Oct 23, 2026
HKG:2361 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,605 | 2,222 | 2,209 | 2,393 | 2,485 | - | |
Market Cap Growth | 3.60% | 0.58% | -7.69% | -3.69% | - | - |
Enterprise Value | 916 | 1,496 | 1,684 | 1,796 | 2,014 | - |
Last Close Price | 3.94 | 5.37 | 5.11 | 5.07 | 4.97 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.08 | 21.37 | 18.76 | 21.29 | 39.42 | - |
Forward PE | - | 14.12 | 22.55 | 33.03 | 88.46 | - |
PS Ratio | 3.21 | 4.76 | 5.14 | 5.48 | 6.16 | - |
PB Ratio | 1.91 | 2.65 | 2.93 | 3.10 | 3.17 | - |
P/TBV Ratio | 1.94 | 2.70 | 2.98 | 3.09 | 3.17 | - |
P/FCF Ratio | 24.30 | 29.76 | 23.21 | 28.61 | 73.81 | - |
P/OCF Ratio | 23.52 | 28.00 | 22.60 | 27.48 | 67.35 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.83 | 3.21 | 3.92 | 4.12 | 4.99 | - |
EV/EBITDA Ratio | 8.93 | 14.17 | 19.03 | 20.34 | 85.21 | - |
EV/EBIT Ratio | 9.79 | 14.68 | 19.65 | 20.98 | 97.62 | - |
EV/FCF Ratio | 13.86 | 20.04 | 17.69 | 21.47 | 59.82 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.06 | 0.08 | 0.13 | 0.17 | 0.27 | 0.13 |
Debt / FCF Ratio | 0.10 | 0.12 | 0.13 | 0.19 | 0.24 | 0.17 |
Net Debt / Equity Ratio | -0.82 | -0.82 | -0.77 | -0.65 | -0.84 | -0.96 |
Net Debt / EBITDA Ratio | -6.84 | -6.53 | -6.59 | -5.66 | -27.73 | -5.72 |
Net Debt / FCF Ratio | -10.43 | -9.24 | -6.13 | -5.97 | -19.47 | -6.84 |
Asset Turnover | 0.52 | 0.50 | 0.50 | 0.50 | 0.54 | 0.61 |
Inventory Turnover | 40.30 | 122.55 | 128.89 | 89.08 | 131.84 | 209.94 |
Quick Ratio | 6.21 | 7.09 | 7.13 | 6.72 | 6.97 | 5.10 |
Current Ratio | 6.53 | 7.21 | 7.24 | 7.23 | 7.18 | 5.21 |
Return on Equity (ROE) | 10.41% | 12.93% | 15.87% | 14.49% | 9.78% | 16.35% |
Return on Assets (ROA) | 6.28% | 6.83% | 6.26% | 6.09% | 1.74% | 7.96% |
Return on Invested Capital (ROIC) | 57.51% | 55.76% | 36.76% | 39.34% | 27.59% | 255.50% |
Return on Capital Employed (ROCE) | 11.50% | 12.10% | 11.20% | 10.90% | 2.60% | 16.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.53% | 4.68% | 5.33% | 4.70% | 2.54% | - |
FCF Yield | 4.12% | 3.36% | 4.31% | 3.50% | 1.35% | - |
Dividend Yield | 1.81% | 1.31% | 2.22% | 1.26% | 0.69% | - |
Payout Ratio | 70.08% | 53.51% | 62.82% | 15.44% | - | 152.37% |
Buyback Yield / Dilution | 7.31% | -10.12% | 3.72% | -3.76% | -10.06% | - |
Total Shareholder Return | 9.12% | -8.81% | 5.94% | -2.51% | -9.37% | - |